Compare the supplemental fluid therapy before and during breast cancer surgery on post-operative nausea and vomiting and pain after cancer breast surgery.
Not Applicable
Recruiting
- Conditions
- Breast cancer.Malignant neoplasm of breast
- Registration Number
- IRCT201602116481N8
- Lead Sponsor
- Semnan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Age between 18-50 years; ASA (American Society of Anesthesiologists) physical status classification I and II.
Exclusion criteria: History of smoking; renal or cardiac disorder; unusual bleeding during surgery; weight above 100 kg; uncontrolled hypertension.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post-operative nausea and vomiting. Timepoint: 1, 4, 8, 24 hours after breast cancer surgery. Method of measurement: Post-operative nausea and vomiting questionnaire (Cortila).
- Secondary Outcome Measures
Name Time Method Severity of pain. Timepoint: 1, 4, 8, and 24 hours after surgery. Method of measurement: Visual analog scale.